Express Scripts : Blue Cross and Blue Shield of Louisiana - Opioid Coverage Changes

Effective January 1, 2018

Author: Erica Lawrence/Wednesday, December 20, 2017/Categories: APCI Choice

Blue Cross and Blue Shield of Louisiana (BCBSLA) is updating their opioid coverage guidelines effective Jan. 1.

• Tylenol® Safety Edit - limits all Tylenol® containing medications to 3 grams or less of Tylenol per day, no exceptions. This applies to opioid and non-opioid drugs.

• Ibuprofen Safety Edit - limits all ibuprofen/short-acting opioid combination medications to 5 tabs or less per day, no exceptions.

• Aspirin Safety Edit - limits all aspirin/short-acting opioid combination medications to 4 grams or less of aspirin per day, no exceptions.

• Short Acting Opioids - prior authorization required for fills greater than a 7-day supply. Prior authorization required for fills greater than a combined 21-day supply within a 60 day period. Certain exceptions will apply for members with cancer or receiving end-of-life care.

• Long Acting Opioids - prior authorization required for new users. Patient must have been previously treated with a short acting opioid and requires around the clock pain control. Certain exceptions will apply for members with cancer or receiving end-of-life care.

*Please see attached for more information.

Comments are only visible to subscribers.